Business Description
Telomir Pharmaceuticals Inc
NAICS : 541713
SIC : 2834
ISIN : US87975F1049
Description
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company leading the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.27 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.23 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.62 | |||||
| 9-Day RSI | 51.04 | |||||
| 14-Day RSI | 51.31 | |||||
| 6-1 Month Momentum % | -15.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.74 | |||||
| Quick Ratio | 1.74 | |||||
| Cash Ratio | 1.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -3.46 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -1081.56 | |||||
| ROA % | -687.63 | |||||
| ROIC % | -182.97 | |||||
| ROCE % | -841.99 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 331.33 | |||||
| Price-to-Tangible-Book | 248.5 | |||||
| EV-to-EBIT | -8.62 | |||||
| EV-to-EBITDA | -8.62 | |||||
| EV-to-FCF | -24.99 | |||||
| Price-to-Net-Current-Asset-Value | 497 | |||||
| Price-to-Net-Cash | 497 | |||||
| Earnings Yield (Greenblatt) % | -11.6 | |||||
| FCF Yield % | -4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TELO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Telomir Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.795 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 51.31 | ||
| 14-Day ATR ($) | 0.60971 | ||
| 20-Day SMA ($) | 4.9865 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 3.11 - 20.72 | ||
| Shares Outstanding (Mil) | 29.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Telomir Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Telomir Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Telomir Pharmaceuticals Inc Frequently Asked Questions
What is Telomir Pharmaceuticals Inc(TELO)'s stock price today?
The current price of TELO is $4.97. The 52 week high of TELO is $20.72 and 52 week low is $3.11.
When is next earnings date of Telomir Pharmaceuticals Inc(TELO)?
The next earnings date of Telomir Pharmaceuticals Inc(TELO) is 2025-02-28 Est..
Does Telomir Pharmaceuticals Inc(TELO) pay dividends? If so, how much?
Telomir Pharmaceuticals Inc(TELO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers